GeoVax develops innovative multi-antigen COVID-19 vaccine targeting vulnerable populations, aligning with new FDA risk-based vaccination guidance. Advanced vaccine platform shows promising clinical results for immunocompromised patients. #COVID19 #VaccineInnovation